ROBUST: A Phase III Study of Lenalidomide plus R-CHOP Versus Placebo plus R-CHOP in Previously Untreated Patients with ABC-Type Diffuse Large B-Cell Lymphoma

ROBUST Trial Investigators

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'ROBUST: A Phase III Study of Lenalidomide plus R-CHOP Versus Placebo plus R-CHOP in Previously Untreated Patients with ABC-Type Diffuse Large B-Cell Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences